| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226352.2 |
Tanespimycin |
Brain lower grade glioma |
0.014108454 |
Resistant |
| ENSG00000226352.2 |
Tanespimycin |
Lung squamous cell carcinoma |
0.007946801 |
Resistant |
| ENSG00000226352.2 |
Tanespimycin |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027596902 |
Sensitive |
